Identification of a Compound That Disrupts Binding of Amyloid-β to the Prion Protein Using a Novel Fluorescence-based Assay
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of a Compound That Disrupts Binding of Amyloid-β to the Prion Protein Using a Novel Fluorescence-based Assay
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 290, Issue 27, Pages 17020-17028
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2015-05-21
DOI
10.1074/jbc.m115.637124
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification and characterization of human Rad51 inhibitors by screening of an existing drug library
- (2014) Anaïs Normand et al. BIOCHEMICAL PHARMACOLOGY
- Peripheral Administration of a Humanized Anti-PrP Antibody Blocks Alzheimer's Disease A Synaptotoxicity
- (2014) I. Klyubin et al. JOURNAL OF NEUROSCIENCE
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo
- (2014) Neng-Wei Hu et al. Nature Communications
- Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked
- (2014) Malin K. Sandberg et al. Nature Communications
- Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease
- (2013) Jens Wagner et al. ACTA NEUROPATHOLOGICA
- An N-terminal Fragment of the Prion Protein Binds to Amyloid-β Oligomers and Inhibits Their Neurotoxicityin Vivo
- (2013) Brian R. Fluharty et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer’s disease
- (2013) Tae-In Kam et al. JOURNAL OF CLINICAL INVESTIGATION
- Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
- (2013) Mathias Jucker et al. NATURE
- Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein
- (2013) Ji Won Um et al. NEURON
- Drug resistance confounding prion therapeutics
- (2013) D. B. Berry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human LilrB2 Is a -Amyloid Receptor and Its Murine Homolog PirB Regulates Synaptic Plasticity in an Alzheimer's Model
- (2013) T. Kim et al. SCIENCE
- Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity
- (2013) Andrew J. Nicoll et al. Nature Communications
- The Complex PrPc-Fyn Couples Human Oligomeric A with Pathological Tau Changes in Alzheimer's Disease
- (2012) M. Larson et al. JOURNAL OF NEUROSCIENCE
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
- (2012) Ji Won Um et al. NATURE NEUROSCIENCE
- PrP Antibodies Do Not Trigger Mouse Hippocampal Neuron Apoptosis
- (2012) P.-C. Klohn et al. SCIENCE
- Preventing Alzheimer's Disease
- (2012) D. J. Selkoe SCIENCE
- Prion Protein Interacts with BACE1 Protein and Differentially Regulates Its Activity toward Wild Type and Swedish Mutant Amyloid Precursor Protein
- (2011) Heledd H. Griffiths et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alzheimer's Disease Brain-Derived Amyloid- -Mediated Inhibition of LTP In Vivo Is Prevented by Immunotargeting Cellular Prion Protein
- (2011) A. E. Barry et al. JOURNAL OF NEUROSCIENCE
- Prion propagation and toxicity in vivo occur in two distinct mechanistic phases
- (2011) Malin K. Sandberg et al. NATURE
- Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites
- (2011) Darragh B. Freir et al. Nature Communications
- Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer's disease model mouse
- (2010) Erika Chung et al. BMC NEUROSCIENCE
- Prion protein and Aβ-related synaptic toxicity impairment
- (2010) Anna Maria Calella et al. EMBO Molecular Medicine
- Interaction between Human Prion Protein and Amyloid-β (Aβ) Oligomers
- (2010) Shugui Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein
- (2010) D. A. Gimbel et al. JOURNAL OF NEUROSCIENCE
- Reversing EphB2 depletion rescues cognitive functions in Alzheimer model
- (2010) Moustapha Cissé et al. NATURE
- The prion protein as a receptor for amyloid-β
- (2010) Helmut W. Kessels et al. NATURE
- Pharmacological chaperone for the structured domain of human prion protein
- (2010) Andrew J. Nicoll et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthetic amyloid- oligomers impair long-term memory independently of cellular prion protein
- (2010) C. Balducci et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
- (2009) Juha Laurén et al. NATURE
- Crystal structure of human prion protein bound to a therapeutic antibody
- (2009) S. V. Antonyuk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now